`
`In re Application of:
`
`BIO-RAD LABORATORIES, INC.
`
`Dated: August 20, 2019
`
`Inventors
`
`Serial No.
`
`Filing Date
`
`For
`
`:
`
`:
`
`:
`
`:
`
`Amy L. HIDDESSEN et al.
`
`Conf. No. 5593
`
`15/707,908
`
`Group Art Unit: 1797
`
`September 18, 2017
`
`Examiner: Jennifer WECKER
`
`DROPLET-BASED ANALYSIS METHOD
`
`Commissioner for Patents
`PO. Box 1450
`
`Alexandria, Virginia 22313-1450
`
`S i r :
`
`INFORMATION DISCLOSURE STATEMENT
`
`UNDER 37 C.F.R. §§ 1.56I 1.97I and 1.98
`
`Applicant is submitting this Information Disclosure Statement pursuant to 37 C.F.R.
`
`§§ 1.56, 1.97, and 1.98 to disclose to the US. Patent and Trademark Office the patents,
`
`publications, applications, and/or other references listed on the enclosed, completed PTO-
`
`1449 form(s). The filing of this Information Disclosure Statement should not be construed as
`
`a representation that a search has been made or as an admission that the listed references
`
`are prior art for this application. Applicant respectfully requests that the listed references be
`
`expressly considered during prosecution of the application, and that the references be
`
`made of record therein and appear among the “references cited” on any patents issuing
`
`therefrom.
`
`Page 1 0f2
`
`—
`
`INFORMATION DISCLOSURE STATEMENT;
`Serial No. 15/707,908; Atty. Docket No. QL|3A05
`
`
`
`CONTENT OF DISCLOSURE
`
`This Information Disclosure Statement includes 33 pages total of PTO-1449 forms.
`
`However, it does n_ot include copies of the references listed on the forms, either because, as
`
`permitted under 37 C.F.R. § 1.98(d), copies already were submitted to, or cited by, the US.
`
`Patent and Trademark Office in an earlier US. application (Serial No. 15/351,354, filed
`
`November 14, 2016; now US. Patent No. 9,764,322) that is relied on here for priority, or
`
`because, as permitted under 37 C.F.R. §1.98(a),
`
`this application was filed on or after
`
`July 1, 2003 and the references are US. patents or published US. patent applications.
`
`TIMING OF DISCLOSURE I FEE INFORMATION
`
`This Information Disclosure Statement is being filed, to the best of the undersigned’s
`
`knowledge, either (1) before the mailing of a first Office action on the merits, or (2) before
`
`the mailing of a first Office action after the filing of a request for continued examination
`
`under 37 C.F.R. § 1.114.Therefore,
`
`in accordance with 37 C.F.R. § 1.97(b), no fee or
`
`statement under 37C.F.R. § 1.97(e) is required.
`
`Please contact the undersigned attorney of record, or his associate, Stan Hollenberg
`
`(Reg. No. 47,658), both at (503) 224-6655, with any questions regarding this Information
`
`Disclosure Statement or the associated application.
`
`Respectfully submitted,
`
`CERTIFICATE OF ELECTRONIC FILING
`
`KOLISCH HARTWELL’ PC
`
`this correspondence is
`I hereby certify that
`/James R. Abne /
`being
`submitted to the US. Patent
`and
`James R. Abney
`Trademark Office via the EFS-Web Electronic
`Registration NO. 42,253
`Filing System on August 20, 2019.
`Customer No. 23581
`_
`M 520 SW. Yamhill Street, Suite 300
`Mandi M- Oarsey
`Portland, Oregon 97204
`Telephone: (503) 224-6655
`Facsimile: (503) 972-9115
`Attorney for Applicant
`
`Page 2 0f 2
`
`—
`
`INFORMATION DISCLOSURE STATEMENT;
`Serial No. 15/707,908; Atty. Docket No. QLI3AO5
`
`